Apimeds Pharmaceuticals US, Inc. (APUS) Free cash flow
Apimeds Pharmaceuticals US, Inc. (APUS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.0MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice